- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05319847
An Exploratory Investigation of a Male Focused Skincare Supplement
September 22, 2022 updated by: Let's Disco
Most skincare products on the market are topical and do not take a holistic approach to understanding skin health.
This trial will examine a dietary supplement designed to support the gut microbiome and promote skin health from an internal perspective.
Research has previously supported the link between the gut microbiome and skin health and the supplement tested in this trial will further the knowledge on the effectiveness of supporting gut health to improve skin outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
38
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Santa Monica, California, United States, 90404
- Citruslabs
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Male
- Between the ages of 18-55
- Frequently experience different forms of acne
- Frequently experience breakouts
- Must be in good health with no long term health conditions
- BMI must be under 40
- Must follow a consistent dietary regimen
- Must be willing to stop any oral supplementation targeting their skin while in the trail
Exclusion Criteria:
- Anyone who does take prescription medication (oral or topical) targeting their skin including reinoid, over the counter retinol, or retinal
- Not willing to stop any oral supplementation targeting their skin
- Severe chronic conditions, including oncological and psychiatric disorders
- Previous severe allergic reactions
- Unwilling the follow the study protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention arm
Daily Skin Supplement - Fountain of Youth
|
Skincare supplement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adult Acne
Time Frame: 12 week
|
Change in overall frequency and intensity of adult acne (Likert Scale 0-5 with higher scores representing a reduction in the appearance of adult acne)
|
12 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
April 15, 2022
Primary Completion (ACTUAL)
June 30, 2022
Study Completion (ACTUAL)
June 30, 2022
Study Registration Dates
First Submitted
March 31, 2022
First Submitted That Met QC Criteria
March 31, 2022
First Posted (ACTUAL)
April 8, 2022
Study Record Updates
Last Update Posted (ACTUAL)
September 26, 2022
Last Update Submitted That Met QC Criteria
September 22, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20239Disco
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Abnormalities
-
Enspectra HealthNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSkin Diseases | Skin Abnormalities | Skin Cancer | Skin Lesion | Skin ConditionUnited States
-
Enspectra HealthNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedSkin Diseases | Skin Abnormalities | Skin Cancer | Skin Lesion | Skin ConditionUnited States
-
Hillel Yaffe Medical CenterUnknown
-
Avita MedicalBiomedical Advanced Research and Development AuthorityTerminatedSkin; DeformityUnited States
-
HealthpointTerminatedSkin AbnormalitiesUnited States
-
Integrative Skin Science and ResearchArbonneCompleted
-
University of MiamiCompletedAging | Skin AbnormalitiesUnited States
-
Koç UniversityKoç University HospitalNot yet recruitingSkin Abnormalities | Pressure Injuries | Skin Failure | Biophysical Parameters of SkinTurkey (Türkiye)
Clinical Trials on Daily Skin Supplement - Fountain of Youth
-
Erasmus Medical CenterActive, not recruitingCKD | Electrolyte and Fluid Balance Conditions | Metabolic AcidosisNetherlands
-
Shahid Beheshti UniversityCompletedSpine SurgeryIran, Islamic Republic of
-
University of California, DavisHelen Keller International; Thrasher Research Fund; Université Polytechnique... and other collaboratorsCompletedDiarrhea | Malaria | Zinc DeficiencyBurkina Faso
-
Hal ChapmanMassachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaboratorsCompletedIdiopathic Pulmonary FibrosisUnited States
-
Tanta UniversityCompletedAtrophic Acne Scar | Trichloroacetic Acid | Subcision | Calcium HydroxylapatiteEgypt
-
Galderma R&DCompletedPhotodamaged Skin | Volume Deficiency of the MidfaceUnited States
-
UMC UtrechtUniversity of Ghana; Ghana Health ServicesUnknownPregnancy Induced HypertensionGhana
-
Trisakti UniversityCompletedUpper Respiratory Tract InfectionIndonesia
-
Peking University First HospitalShanghai 10th People's Hospital; Beijing Tsinghua Chang Gung Hospital; Guizhou... and other collaboratorsRecruitingDelirium | Surgery | Bladder Cancer | Benzodiazepines | Cancer RecurrenceChina
-
St. Justine's HospitalCompleted